quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:47:09·267d
INSIDERFiling
Ikena Oncology Inc. logo

Director Stampacchia Otello converted options into 379 shares and bought $7,999,924 worth of shares (267,556 units at $29.90) (SEC Form 4)

IKNA· Ikena Oncology Inc.
Health Care
Original source

Companies

  • IKNA
    Ikena Oncology Inc.
    Health Care

Recent analyst ratings

  • May 29UpdateWedbush$2.00
  • Sep 22UpdateWedbush$11.00
  • May 4UpdateH.C. Wainwright$18.00
  • Dec 23UpdateHC Wainwright & Co.$25.00
  • Aug 13UpdateCredit Suisse$27.00

Related

  • SEC265d
    Ikena Oncology Inc. filed SEC Form 8-K: Leadership Update, Other Events
  • INSIDER267d
    SEC Form 4 filed by Chief Executive Officer Yarema Kristin
  • INSIDER267d
    Director Orbimed Advisors Llc was granted 83,611 shares (SEC Form 4)
  • SEC267d
    Amendment: SEC Form SCHEDULE 13D/A filed by Ikena Oncology Inc.
  • INSIDER267d
    Director Bonita David P converted options into 379 shares and bought $2,499,969 worth of shares (83,611 units at $29.90) (SEC Form 4)
  • INSIDER268d
    Chief Financial Officer Marango Jotin was granted 15,776 shares and covered exercise/tax liability with 4,630 shares (SEC Form 4)
  • INSIDER268d
    Principal Accounting Officer Butler Erin was granted 3,051 shares (SEC Form 4)
  • INSIDER268d
    SEC Form 3 filed by new insider Butler Erin
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022